InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by McAdory, John Bearden. Officer active across 1 company, notably Oncolytics Biotech Inc.. In total, 3 reports have been logged. History available since 1 June 2026. The latest transaction was disclosed on 1 June 2026 (50 - Grant of options). Regulator: SEDI. The full history is openly available.
3 of 3 declarations